Perspective Investments vs Begin Period Cash Flow Analysis

CATX Stock

3.69 0.22 6.34%

Perspective Therapeutics financial indicator trend analysis is much more than just breaking down Perspective Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Perspective Therapeutics is a good investment. Please check the relationship between Perspective Therapeutics Investments and its Begin Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Perspective Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.

Investments vs Begin Period Cash Flow

Investments vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Perspective Therapeutics Investments account and Begin Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Perspective Therapeutics' Investments and Begin Period Cash Flow is 0.46. Overlapping area represents the amount of variation of Investments that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Perspective Therapeutics, assuming nothing else is changed. The correlation between historical values of Perspective Therapeutics' Investments and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Investments of Perspective Therapeutics are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Investments i.e., Perspective Therapeutics' Investments and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.46

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Perspective Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Perspective Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Perspective Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.Selling General Administrative is likely to rise to about 22.1 M in 2024, whereas Tax Provision is likely to drop (2.5 M) in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	18.2M	17.4M	40.9M	43.0M
Cost Of Revenue	6.2M	5.5M	4.9M	4.2M

Total Operating Expenses Cost Of Revenue

Perspective Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Good Will	Non Currrent Assets Other	Other Assets
Total Assets		-0.85	0.72	0.82	0.99	0.76	-0.24	-0.65	-0.87	0.82	0.52	0.78	0.94	0.33	0.16	0.79	0.91	0.18	0.89	0.81	0.57	0.63	0.83	0.42	-0.09	0.86
Short Long Term Debt Total	-0.85		-0.48	-0.61	-0.87	-0.59	-0.01	0.65	0.67	-0.62	-0.56	-0.52	-0.86	-0.27	-0.17	-0.52	-0.87	-0.46	-0.73	-0.58	-0.66	-0.46	-0.82	-0.12	0.18	-0.9
Other Current Liab	0.72	-0.48		0.96	0.61	0.86	0.0	-0.07	-0.67	0.95	-0.09	0.98	0.45	-0.17	-0.4	0.96	0.62	-0.27	0.53	0.96	-0.13	0.33	0.26	0.25	0.11	0.68
Total Current Liabilities	0.82	-0.61	0.96		0.72	0.9	-0.06	-0.14	-0.8	1.0	-0.02	0.99	0.57	-0.01	-0.16	0.99	0.74	-0.06	0.67	1.0	0.0	0.42	0.44	0.31	-0.1	0.78
Total Stockholder Equity	0.99	-0.87	0.61	0.72		0.68	-0.26	-0.74	-0.84	0.73	0.63	0.67	0.98	0.39	0.24	0.69	0.9	0.24	0.9	0.71	0.69	0.64	0.89	0.42	-0.08	0.84
Property Plant And Equipment Net	0.76	-0.59	0.86	0.9	0.68		-0.13	-0.22	-0.76	0.9	0.08	0.89	0.55	0.24	-0.17	0.9	0.8	-0.06	0.63	0.9	0.05	0.46	0.44	0.35	-0.09	0.73
Current Deferred Revenue	-0.24	-0.01	0.0	-0.06	-0.26	-0.13		0.21	0.5	-0.1	-0.19	-0.1	-0.25	-0.53	-0.39	-0.11	-0.36	-0.09	-0.48	-0.07	-0.24	-0.8	-0.39	-0.97	-0.11	-0.21
Net Debt	-0.65	0.65	-0.07	-0.14	-0.74	-0.22	0.21		0.43	-0.14	-0.99	-0.09	-0.86	-0.58	-0.27	-0.1	-0.57	-0.11	-0.61	-0.13	-0.92	-0.44	-0.82	-0.22	-0.19	-0.4
Retained Earnings	-0.87	0.67	-0.67	-0.8	-0.84	-0.76	0.5	0.43		-0.83	-0.3	-0.77	-0.75	-0.43	-0.27	-0.78	-0.88	-0.19	-0.91	-0.8	-0.37	-0.77	-0.79	-0.68	0.12	-0.83
Accounts Payable	0.82	-0.62	0.95	1.0	0.73	0.9	-0.1	-0.14	-0.83		-0.02	0.99	0.58	0.0	-0.12	0.98	0.76	0.0	0.69	1.0	0.02	0.46	0.46	0.35	-0.13	0.81
Cash	0.52	-0.56	-0.09	-0.02	0.63	0.08	-0.19	-0.99	-0.3	-0.02		-0.07	0.78	0.59	0.3	-0.06	0.46	0.13	0.52	-0.03	0.93	0.35	0.75	0.16	0.2	0.28
Non Current Assets Total	0.78	-0.52	0.98	0.99	0.67	0.89	-0.1	-0.09	-0.77	0.99	-0.07		0.51	-0.04	-0.22	0.99	0.69	-0.14	0.63	1.0	-0.07	0.42	0.37	0.35	-0.03	0.73
Cash And Short Term Investments	0.94	-0.86	0.45	0.57	0.98	0.55	-0.25	-0.86	-0.75	0.58	0.78	0.51		0.46	0.3	0.53	0.84	0.26	0.86	0.56	0.82	0.6	0.93	0.36	-0.04	0.75
Net Receivables	0.33	-0.27	-0.17	-0.01	0.39	0.24	-0.53	-0.58	-0.43	0.0	0.59	-0.04	0.46		0.48	0.02	0.48	0.19	0.46	0.0	0.58	0.54	0.63	0.49	-0.05	0.19
Common Stock Shares Outstanding	0.16	-0.17	-0.4	-0.16	0.24	-0.17	-0.39	-0.27	-0.27	-0.12	0.3	-0.22	0.3	0.48		-0.19	0.21	0.76	0.35	-0.17	0.53	0.33	0.5	0.32	-0.69	0.07
Non Current Liabilities Total	0.79	-0.52	0.96	0.99	0.69	0.9	-0.11	-0.1	-0.78	0.98	-0.06	0.99	0.53	0.02	-0.19		0.7	-0.13	0.64	0.99	-0.05	0.43	0.39	0.36	-0.06	0.72
Inventory	0.91	-0.87	0.62	0.74	0.9	0.8	-0.36	-0.57	-0.88	0.76	0.46	0.69	0.84	0.48	0.21	0.7		0.34	0.87	0.73	0.54	0.72	0.84	0.51	-0.16	0.93
Other Current Assets	0.18	-0.46	-0.27	-0.06	0.24	-0.06	-0.09	-0.11	-0.19	0.0	0.13	-0.14	0.26	0.19	0.76	-0.13	0.34		0.26	-0.08	0.45	0.22	0.43	0.05	-0.79	0.36
Other Stockholder Equity	0.89	-0.73	0.53	0.67	0.9	0.63	-0.48	-0.61	-0.91	0.69	0.52	0.63	0.86	0.46	0.35	0.64	0.87	0.26		0.66	0.58	0.64	0.84	0.62	-0.09	0.8
Total Liab	0.81	-0.58	0.96	1.0	0.71	0.9	-0.07	-0.13	-0.8	1.0	-0.03	1.0	0.56	0.0	-0.17	0.99	0.73	-0.08	0.66		-0.02	0.42	0.42	0.32	-0.08	0.76
Total Current Assets	0.57	-0.66	-0.13	0.0	0.69	0.05	-0.24	-0.92	-0.37	0.02	0.93	-0.07	0.82	0.58	0.53	-0.05	0.54	0.45	0.58	-0.02		0.45	0.84	0.21	-0.07	0.41
Short Term Debt	0.63	-0.46	0.33	0.42	0.64	0.46	-0.8	-0.44	-0.77	0.46	0.35	0.42	0.6	0.54	0.33	0.43	0.72	0.22	0.64	0.42	0.45		0.72	0.85	0.0	0.62
Common Stock	0.83	-0.82	0.26	0.44	0.89	0.44	-0.39	-0.82	-0.79	0.46	0.75	0.37	0.93	0.63	0.5	0.39	0.84	0.43	0.84	0.42	0.84	0.72		0.46	-0.15	0.73
Good Will	0.42	-0.12	0.25	0.31	0.42	0.35	-0.97	-0.22	-0.68	0.35	0.16	0.35	0.36	0.49	0.32	0.36	0.51	0.05	0.62	0.32	0.21	0.85	0.46		0.09	0.39
Non Currrent Assets Other	-0.09	0.18	0.11	-0.1	-0.08	-0.09	-0.11	-0.19	0.12	-0.13	0.2	-0.03	-0.04	-0.05	-0.69	-0.06	-0.16	-0.79	-0.09	-0.08	-0.07	0.0	-0.15	0.09		-0.13
Other Assets	0.86	-0.9	0.68	0.78	0.84	0.73	-0.21	-0.4	-0.83	0.81	0.28	0.73	0.75	0.19	0.07	0.72	0.93	0.36	0.8	0.76	0.41	0.62	0.73	0.39	-0.13

Click cells to compare fundamentals

Perspective Therapeutics Account Relationship Matchups

Perspective Therapeutics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	8.7M	70.4M	64.4M	58.1M	97.9M	102.8M
Other Current Liab	(321K)	89K	1.0M	(406K)	5.1M	5.3M
Total Current Liabilities	1.6M	1.8M	2.3M	2.7M	15.7M	16.4M
Total Stockholder Equity	5.7M	67.4M	61.3M	54.6M	75.2M	78.9M
Property Plant And Equipment Net	2.7M	2.7M	2.5M	2.1M	6.3M	6.6M
Net Debt	(1.4M)	(63.1M)	(55.4M)	(21.0M)	(18.9M)	(17.9M)
Retained Earnings	(87.9M)	(91.3M)	(98.6M)	(105.9M)	(152.4M)	(160.1M)
Accounts Payable	654K	730K	966K	1.5M	6.1M	6.4M
Cash	2.4M	63.8M	55.9M	21.0M	9.2M	10.4M
Non Current Assets Total	3.2M	3.1M	5.1M	2.3M	81.1M	85.1M
Cash And Short Term Investments	2.4M	63.8M	55.9M	43.8M	50.3M	52.8M
Net Receivables	2.0M	2.0M	1.6M	1.4M	1.2M	986.6K
Common Stock Shares Outstanding	67.6M	103.8M	14.2M	142.1M	28.2M	34.8M
Liabilities And Stockholders Equity	8.7M	70.4M	64.4M	58.1M	66.8M	70.1M
Non Current Liabilities Total	621K	1.4M	1.2M	896K	7.0M	7.4M
Inventory	645K	980K	1.4M	1.4M	1.6M	1.7M
Other Current Assets	426K	481K	27K	6.7M	45K	42.8K
Other Stockholder Equity	93.6M	158.6M	159.7M	160.4M	144.4M	245.5M
Total Liab	3.0M	3.0M	3.2M	3.4M	22.7M	23.8M
Total Current Assets	5.5M	67.3M	59.3M	53.2M	16.8M	14.5M
Common Stock	55K	67K	69K	142K	127.8K	103.4K
Non Currrent Assets Other	137K	76K	2.5M	(2.3M)	182K	294.6K
Intangible Assets	138K	130K	107K	86K	50.4M	52.9M
Net Invested Capital	5.7M	67.4M	61.3M	76.9M	88.4M	48.6M
Net Working Capital	3.9M	65.5M	57.1M	1.2M	1.3M	1.3M
Property Plant And Equipment Gross	10.3M	10.0M	10.0M	7.0M	6.3M	5.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Perspective Stock Analysis

When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Perspective Investments vs Begin Period Cash Flow Analysis

Investments vs Begin Period Cash Flow

Investments vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Investments

Begin Period Cash Flow

Perspective Therapeutics fundamental ratios Correlations

Perspective Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Perspective Therapeutics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Perspective Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Accounts Payable	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Accounts Payable
Total Liab	+ 1.0	Non Current Assets Total
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Current Liabilities

Cash	- 0.99	Net Debt
Good Will	- 0.97	Current Deferred Revenue
Total Current Assets	- 0.92	Net Debt
Other Stockholder Equity	- 0.91	Retained Earnings
Other Assets	- 0.9	Short Long Term Debt Total
Inventory	- 0.88	Retained Earnings